Background. Recent studies in man have shown that cerebral blood flow increases during inhalation of nitrous oxide (N 2 O), a finding which is believed to be a result of an increased cerebral metabolic rate (CMR). However, this has not previously been evaluated in man.
Nitrous oxide (N 2 O) has been used for anaesthesia during neurosurgical procedures for half a century, as it was previously thought to be inert. 1 However, in the 1970s, it was shown that N 2 O had potentially striking effects on intracranial pressure (ICP). 2 3 The literature regarding the effects of N 2 O on the brain is still equivocal, probably due to species differences, but also because of interactions with other drugs or interventions. In humans, evidence supporting the conclusion that N 2 O is a cerebral vasodilator in the absence of other interventions has been obtained from both two-and three-dimensional cerebral blood flow (CBF) studies. 4 -6 Three-dimensional CBF measurements during N 2 O 50% inhalation show that CBF increased in all regions, even though not evenly distributed in the brain. 6 The reason for this increase in flow is still unknown, but it may theoretically be due to an increased cerebral metabolism 7 or an influence of N 2 O on the cerebral vessels, 8 for instance through release of vasoactive mediators.
In order to explore the former hypothesis, the aim of the present study was designed to evaluate the effect of N 2 O 50% on the cerebral metabolic rate for glucose (CMR glu ) and its distribution using a three-dimensional positron emission tomography (PET) technique.
Methods
Ten male volunteers, age 25-40 yr (mean 31 yr), participated in the study. The ethics committee for human studies and the isotope committee at the University of Lund approved the protocol. Written informed consent was obtained from each participant.
The participants breathed spontaneously into a facemask held in place by a rubber head strap. After eliminating air leaks, the volunteers inhaled one of two different gas mixtures starting 15 min before and continued 35 min after the injection of 2-( 18 F)fluoro-2-deoxy-D-glucose (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) FDG). The inhaled gas mixtures were oxygenenriched air (O 2 30%) and a mixture of N 2 20%, O 2 30%, and N 2 O 50%. Oxygen-enriched air was compressed air and O 2 mixed with flow meters (Unit 760, Siemens, Elema, Solna, Sweden) whereas N 2 O 50% with O 2 30% in N 2 was delivered as a pre-mixed precision gas produced by Alfax (Malmö, Sweden). Each subject served as it own control, starting by either inhaling N 2 O 50% or O 2 30% in a randomized order succeeded by the other gas mixture. A PET scan was performed in each situation within 60 min after the FDG injections. The results were evaluated after six investigations, and as the three subjects who inhaled N 2 O 50% first had remaining effects of N 2 O on the succeeding PET scans, all the rest of the investigations (four) were done by starting with O 2 30%. The data from the three subjects are included in the physiological values, but the results from their PET scanning are presented separately, and none of these data was included in the main study. Two volunteers breathed air twice in order to control the validity of the method. One participant had discomfort by inhaling N 2 O and no data from this subject are included in any part of the study.
PET examinations were performed with a PC384-7B scanner (Scanditronix, Uppsala, Sweden). The four ring detector system generated four main slices and three cross slices, with an approximate slice thickness of 13 mm. The mean sensitivity of the scanner was 675 cps (kBq ml
for the main slices and 945 cps (kBq ml 21 ) 21 for the cross slices. Corrections for random and scattered events were made. The attenuation was calculated from contours using a soft-tissue attenuation coefficient.
The 2-18 FDG was synthesized using 18 F from the Lund electrostatic tandem accelerator with a proton beam of 6.0 MeV and produced by the 18 O( p,n) 18 F reaction, 9 and by fluorination of the precursor 1,3,4,6-tetra-O-acetyl-2-Otrifluoro-methane-b-D-mannopyranose according to a method described by Toorongian and colleagues. 10 The radiochemical purity of FDG was better than 95%.
PET images were acquired within 60 min after administration of 50-150 MBq FDG, with the highest dose at the second measurement, by a 2 min i.v. injection into a peripheral vein in the arm. Venous blood samples were drawn from the other arm at appropriate intervals for quantification (every 20 s for 4 min, every 60 s for 10 min, and every 5 min up to a total of 35 min). When the blood samples had been centrifuged, radioactivity in the plasma (C p ) was measured using a well counter. Blood glucose (C g ) values were obtained, from the same site, immediately before, 10 and 35 min after injection of FDG. Two FDG studies were made on each subject with a time interval of approximately 2 h. The three-dimensional metabolic rate of glucose in the brain was recorded, parallel to the orbito-meatal (OM) line, with the centre of the lowest slice located 1 cm below the OM line. The head position was controlled using light beams on the external auditory meatus and the nasion as landmarks. Each study consisted of two separate scans (2Â10 min), in between which the couch was moved half a plane separation (6.75 mm) in order to get a higher axial sampling rate. The CMR glu were calculated using the test-retest method developed by Brooks and colleagues, 11 which takes into account the residual activity from the first investigation in the calculation of the second.
A number of blood samples were taken during a 35 min period after each FDG-injection, and the activity in plasma was measured. These curves were extrapolated by fitting a monoexponential function to the tail of the curve (the last 25 min). The first extrapolated curve was adjusted to match a sample taken immediately before the second injection. An example of a plasma activity curve is shown in Figure 1 .
Tomographic images were reconstructed by filtered back projection using a Hanning reconstruction filter with a cut-off frequency of 2.1 cm
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. The image matrix size was 128Â128 and the pixel size 2.2 mm.
The calculation of the second measurement demanded that the images from the two studies were perfectly registered. This was accomplished first by carefully positioning the subjects in the same way for the two studies using line-laser for positioning, and secondly by shifting and rotating the images interactively.
Standard sets of regions of interest (ROIs) corresponding to the brain lobes, cerebellum, pons, thalamus, and basal ganglia were analysed by a ROI analysis program (Amersham, UK). The program works with anatomical templates from a CT brain atlas. 12 The templates were applied to the brain slices and scaled to the actual head size according to the external brain diameters. Three-dimensional cerebral ROIs were calculated from adjoining ROIs in different brain slices representing the same structure. With the aid of the ROIs, the mean CMR glu in different brain regions and the global mean CMR glu was calculated.
The quantities of CO 2 , O 2 , and N 2 O in the inspiratory and expiratory gas mixtures were continuously measured along with the pulse rate and arterial haemoglobin oxygen saturation (Sa O 2 ), with an Ohmeda 4700 OxiCap (BOC Health Care, Louisville, KY, USA). Non-invasive arterial pressure was recorded with 5 min intervals (Colin Press-Mate, Colin Electronics, Japan) during the inhalation of gas. At the end of the study, a blood sample was withdrawn to measure the haemoglobin concentration.
Global effects of N 2 O on the CMR glu were analysed by two factor repeated measures analysis of variance (ANOVA) with correction for departure from sphericity for the interaction data. 13 As the investigations were test-retest situations with residual activity from the first investigation, this activity had to be subtracted analysing the second measurement. The increased noise level of the subtraction method, in combination with the limited number of subjects, will limit our findings to major CMR glu changes in the order of 10-15% or more, whereas smaller changes will not be detected.
The effects of N 2 O on the rCMR glu (ROI) was tested with primary component analysis (PCA) in order to identify functionally coupled regions followed by repeated measures ANOVAs of the factor scores. In each ANOVA, the effect of N 2 O on the rCMR glu (in per cent of mean) was tested. Post hoc testing with paired Student's t-test (twotailed) was performed when the ANOVA indicated significant effects in order to clarify which regional effect mainly contributed to the significance.
The relative change in distribution was calculated as the differences between the relative rCMR glu values for measurements, with and without N 2 O. Physiological data were analysed by two factor repeated measures ANOVA with correction for departure from sphericity for the interaction data. 18 Significant ANOVA interactions were further regionally analysed with Student's paired t-test. P 0.05 was considered statistically significant. All values are given as mean (SD). All statistical analyses were performed using the Stat View program version 5.0.1 for Windows (SAS Institute, Cary, NC, USA).
Results
Physiological values for inhalation of oxygen-enriched air and for inhalation of N 2 O 50% is presented in Table 1 significantly, whereas it induced a significant change in the distribution (F¼7.7, P,0.0001) (Fig. 2, Table 2 ). PCA analysis identified the factors explaining 89% of the variance in the ROIs. These were high negative loading in frontal, parietal, and temporal cortex vs positive loading in pons; high negative loading in cerebellum and positive in thalamus as well and basal ganglia; and finally high negative loading in the occipital region. Only high negative loading in cerebellum and positive in thalamus as well and basal ganglia reached the level of significance (P,0.0001).
Comparing the individual ROIs, N 2 O significantly increased metabolism in thalamus by 22 (23%) (t¼2.59, P,0.05) and basal ganglia by 14 (17)% (t¼2.20, P,0.05) (Fig. 3) .
In the different ROIs, inhalation of N 2 O 50% changed the metabolism as shown in Figure 3 . Representative PET and SPECT scans (CBF) under the same conditions with and without N 2 O are presented in Figure 4 .
There was a significant difference of the results whether N 2 O or oxygen-enriched air was inhaled first (F¼5.48, P,0.0001). In the three volunteers who started with N 2 O when air was inhaled. The effects on the different ROIs are presented in Figure 5 .
Discussion
During inhalation of oxygen-enriched air, the global CMR glu of the human brain was 27 mmol 100 g 21 min
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that is in accordance with former similar studies. 14 In the present study, inhalation of N 2 O 50% in healthy young men resulted in only a minor and non-significant increase in global CMR glu . This is in fact not a surprising finding as no human study has demonstrated any increase in CMR due to N 2 O inhalation; previous studies were limited by the fact that another anaesthetic drug was present during the investigation 15 16 and which has been used to explain the lack of effect of N 2 O on CMR. 17 In the study by Kaisti and colleagues, 16 where adjunct of N 2 O counteracts the CMRO 2 and CBF reduction by propofol and sevoflurane, the amounts of propofol and sevoflurane given is lowered when N 2 O was added, in order to keep the anaesthetic level constant. The effect could be due to a reduction in the basic anaesthesia or an increase in CMR due to the N 2 O addition. In support of this assumption, N 2 O generally increased the CMR in animals if administered alone, 7 but this increase in metabolism could be reduced or abolished by augmenting the anaesthetic level through addition of other anaesthetics. The animal studies, together with the fact that N 2 O changes the EEG pattern in humans, 15 18 19 have been used to postulate that N 2 O Xe and SPECT from a former study 10 and the bottom figures, the cerebral metabolism (CMR glu ), from this study, in concomitant situations. N 2 O and cerebral metabolism increases CMR also in man, which our study does not support.
Compared with inhalation of oxygen-enriched air, N 2 O 50% inhalation made the participants hyperventilate with a significant lowering of the E 0 CO 2 by 0.5 kPa (4 mm Hg), which is in accordance with other studies. 4 5 It is generally accepted that changes in CO 2 affect the CBF, but not CMR which remains unaffected of CO 2 changes within arterial CO 2 levels of 2 -10 kPa (15 -80 mm Hg). 20 One possible reason for the reduced effect of N 2 O on the CMR glu , as suggested by Stapleton and colleagues, 21 can be explained by an adaptation to lower anxiety during the second PET scan. However, most of the participants in the present study had also participated in a former study evaluating the effect of N 2 O on the rCBF, 6 which would be expected to relieve the anxiety effect of these participants. Furthermore, N 2 O 50% inhalation has profound psychogenic effects, 4 -6 making it difficult to extrapolate the findings of Stapleton and colleagues 21 to our experimental condition. We also noted that participants who started with inhalation of N 2 O 50% tended to increase global CMR glu during the succeeding inhalation of oxygen-enriched air. As volunteers inhaling air twice did not change their metabolism, this observation is best explained by residual effects of N 2 O on the succeeding CMR glu , and does not favour the view that CMR should generally be decreased at the second measurement.
Inhalation of N 2 O 50% has been reported to increase global CBF by 22-40% in man. 4 -6 This effect is mainly believed to be due to the mental activation by N 2 O as changes in rCBF should normally be directly coupled to changes in rCMR. 22 In this study, inhalation of N 2 O 50% induced a non-significant increase in the global CMR glu of 10% (Fig. 4) . This contrasts to the earlier findings where CBF increased by 22 -40%, indicating that there might be a direct or indirect effect on the cerebral arteries in addition to the cerebral metabolic effect. In support of this theory, addition of N 2 O to an isoflurane anaesthesia during normocapnia resulted in an increased CBF without any influence on the rCBF pattern created by isoflurane. 23 This uncoupling between CBF and CMR has not been found to be due to a direct effect on the human cerebral vessels by N 2 O, 6 opening up for alternative explanations to this discrepancy.
Inhalation of N 2 O altered the regional distribution of CMR glu , which increased in thalamus and basal ganglia. Utilizing the same technique to identify ROIs, N 2 O inhalation was found to augment rCBF in most brain regions, although thalamus and basal ganglia were among the regions with the greatest change. 6 Even though we do not find a complete match between flow and metabolism, such conformity has been verified for inhalation of N 2 O 20%. 24 The correlation between flow and metabolism may therefore explain the regional cerebral flow pattern found during N 2 O inhalation, 6 which, however, is generally increased (uncoupled) due to the higher concentration of N 2 O inhaled. The flow pattern gave the impression that N 2 O inhalation increased flow through regions anatomically associated with the limbic system. 25 In support of the theory of limbic system activation by N 2 O, we have previously reported 6 that N 2 O stimulated thoughts and emotions, which normally are dealt with by the limbic system. In addition, former reports have shown an increased EEG activity in the limbic regions in cats 26 and in humans 27 28 during N 2 O inhalation. In conclusion, inhalation of N 2 O 50% resulted in a small and non-significant increase in global CMR glu . This effect on the global metabolism was mainly attributed to an increased metabolism in thalamus and basal ganglia. The metabolic effect of N 2 O may linger in the brain more than 1 h after clinical recovery from anaesthesia.
